Cullinan Therapeutics, Inc.
NASDAQCullinan Therapeutics enters the back half of August with its stock up 18% over the past month — yet options traders are growing more defensive even as the rally continues. The clearest tension is in options positioning. The put/call ratio has climbed to 1.05, more than 2.6 standard deviations above its 20-day average of 0.93 — the most hedged reading in months relative to recent…
Snapshot as of 9 Sept 2026
Cullinan Therapeutics enters the back half of August with its stock up 18% over the past month — yet options traders are growing more defensive even as the rally continues. The clearest tension is in options…
Cullinan Therapeutics heads into its June 16 earnings event with options traders the most defensively positioned they have been in months, even as short sellers quietly trimmed exposure this week. The options signal is…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CGEM — free to start on ORTEX.
Sign up for free →Open CGEM on ORTEX